Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
The Lancet. Oncology|February 9, 2020
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trialRobert H Jones, Angela Casbard, Margherita Carucci, et al.Clinical Trials (London, England)|January 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancerLouise C Brown, Janet Graham, David Fisher, et al.The Lancet. Oncology|June 7, 2022
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trialSacha J Howell, Angela Casbard, Margherita Carucci, et al.Plos One|May 3, 2013
Detection and strain typing of ancient Mycobacterium leprae from a medieval leprosy hospitalG Michael Taylor, Katie Tucker, Rachel Butler, et al.The Lancet. Oncology|April 11, 2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trialJohn Primrose, Stephen Falk, Meg Finch-Jones, et al.Journal of Clinical Pathology|November 29, 2014
Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trialJoshua R Kapp, Tim Diss, James Spicer, et al.European Journal of Human Genetics : EJHG|July 15, 2005
Early onset seizures and Rett-like features associated with mutations in CDKL5Julie C Evans, Hayley L Archer, James P Colley, et al.Current Biology : CB|January 24, 2012
Disrupted circadian rhythms in a mouse model of schizophreniaPeter L Oliver, Melanie V Sobczyk, Elizabeth S Maywood, et al.Cell|September 3, 2013
The CRTC1-SIK1 pathway regulates entrainment of the circadian clockAarti Jagannath, Rachel Butler, Sofia I H Godinho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N TrialRichard A Adams, David J Fisher, Janet Graham, et al.Pageof 19